Back to search

Molecule Structure

Scientific Name


Description of the Drug

Mobocertinib is an oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Not Available

Company Owner(s)

Takeda Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Epidermal growth factor receptor erbB1 SINGLE PROTEIN INHIBITOR CHEMBL203

Unichem Links

SureChEMBL SCHEMBL17373133
PharmGKB PA166268804
Human Metabolome Database HMDB0304841
DrugBank DB16390
PubChem 118607832
BindingDB 368374
ChemicalBook CB74676602
Guide to Pharmacology 10468